Log In
Print
BCIQ
Print
Print this Print this
 

Suboxone, buprenorphine/naloxone

  Manage Alerts
Collapse Summary General Information
Company Reckitt Benckiser Group plc
DescriptionBuprenorphine and naloxone tablet
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsTreat opiate dependency
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today